BMC Cardiovascular Disorders

OCT 14, 2026 · JOURNAL ARTICLE

Association between lactate-to-albumin ratio and mortality in obese patients with atrial fibrillation

BMC Cardiovascular Disorders

The lactate-to-albumin ratio (LAR) is a composite biomarker reflecting both metabolic stress and nutritional status. This study aimed to explore its association with 28-day mortali

OCT 14, 2026 · JOURNAL ARTICLE

Feeling of loneliness and determinants of health as correlates of cardiometabolic syndrome: a population-based US study

BMC Cardiovascular Disorders

Loneliness is an emerging social health factor that has been linked to cardiovascular outcomes and early mortality. Cardiometabolic syndrome is characterized by a combination of me

OCT 8, 2026 · JOURNAL ARTICLE

Metabolic health and obesity phenotypes in relation to incident heart failure: a systematic review and meta-analysis

BMC Cardiovascular Disorders

Abstract Background Obesity is an established risk factor for incident heart failure, but whether the associated risk depends on metabolic health rather than body size alone remain

OCT 7, 2026 · JOURNAL ARTICLE

Metabolic obesity phenotypes and the onset and progression of ischaemic heart disease: a multi-state analysis in UK Biobank

BMC Cardiovascular Disorders

To examine associations of metabolic obesity phenotypes with the onset and progression of ischaemic heart disease (IHD) and potential biomarker pathways. We analysed 336,386 UK Bio

SEP 26, 2026 · JOURNAL ARTICLE

Horos-based cardiac virtual anatomy as an adjunct to nurse training: a single-center randomized study

BMC Cardiovascular Disorders

To determine whether adding Horos-based, patient-specific three-dimensional cardiac visualization to routine case-based ward-round training produced greater longitudinal improvemen

SEP 24, 2026 · JOURNAL ARTICLE

The effect of SGLT2i on cardiovascular outcomes after PCI in patients with AMI and type 2 diabetes mellitus: a retrospective clinical study

BMC Cardiovascular Disorders

To evaluate the association between sodium-glucose cotransporter 2 inhibitors (SGLT2i) use and cardiovascular outcomes after percutaneous coronary intervention (PCI) in patients wi

SEP 16, 2026 · JOURNAL ARTICLE

Triglyceride glucose index, metabolic comorbidity, and cardiovascular disease: a national cohort study

BMC Cardiovascular Disorders

The triglyceride-glucose (TyG) index, a widely accepted surrogate biomarker of insulin resistance, strongly predicts cardiovascular disease (CVD) risk. However, the mediating role

SEP 10, 2026 · JOURNAL ARTICLE

Association between modified cardiometabolic index and stroke events among individuals with overweight or obesity across cardiovascular-kidney-metabolic syndrome stages 1–4: a prospective cohort study

BMC Cardiovascular Disorders

A prospective cohort study with adequate sample size and multivariate adjustment showing a graded dose-response association between modified cardiometabolic index and stroke risk in a high-risk population, but limited by observational design, moderate effect sizes, and lack of established clinical utility.